BioLife Solutions Inc (BLFS) Shares Surge 3.5% -- What GF Score of 67 Tells InvestorsGuruFocus · 1 day ago
BioLife Solutions Shareholders Approve Repligen Merger AgreementMarketBeat · Oct 5, 2026
BioLife Solutions, Inc. (NASDAQ:BLFS) Stock Has Consensus Target Price of $31.38 According to BrokeragesDefense World · Oct 5, 2026
Are BLFS, FTHM, AUUD, VRME Obtaining Fair Deals for their Shareholders?GuruFocus · Sep 11, 2026
Are BLFS, FTHM, AUUD, VRME Obtaining Fair Deals for their Shareholders?PRNewsWire · Sep 11, 2026
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFSBusiness Wire · Sep 10, 2026BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | $0.03 | $0.91 | Beat |
| May 7, 2026 | $0.01 | $0.04 | Beat |
| Feb 26, 2026 | -$0.02 | $0.04 | Beat |
| Nov 6, 2025 | $0.00 | $0.04 | Beat |
| Aug 7, 2025 | -$0.02 | -$0.33 | Miss |
| May 8, 2025 | -$0.03 | $0.04 | Beat |